Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Developed by the Australian company Clinuvel Pharmaceuticals under the commercial name Scenesse , afamelanotide received EMA approval in 2014 and FDA approval in 2019 for the prevention of phototoxicity in patients with erythropoietic protoporphyria (EPP), a rare orphan disease
It was found that the PI3K/AKT and MAPK signal pathways were the key targets of BC against IS ( 2) Conduct larger-scale and more standardized pharmacological experiments and clinical trials to actively evaluate the efficacy and safety of BC in IS treatment
In fact, carbon-13 nuclear magnetic resonance ( 13 C-NMR) spectroscopy showed that the acetyl moiety of acetyl-l-carnitine was metabolised in both astrocytes and neurons to generate energy [25]
In 2024, life sciences stocks surged by 4.2%, adding USD 386 billion in value to reach a staggering USD 9.6 trillion, much of it driven by obesity-focused pharma companies
US$ 27.02
US$ 28.81
US$ 27.79
US$ 20.63
US$ 29.37
US$ 27.03
US$ 28.74
US$ 27.27
US$ 27.71
